Your browser doesn't support javascript.
loading
STOML2 as a novel prognostic biomarker modulates cell proliferation, motility and chemo-sensitivity via IL6-Stat3 pathway in head and neck squamous cell carcinoma.
Qu, Haiou; Jiang, Weifeng; Wang, Yongxu; Chen, Peng.
  • Qu H; Department of Thyroid and Breast Surgery, The First People's Hospital of Wenling Wenling 317500, China.
  • Jiang W; Department of Thyroid and Breast Surgery, The First People's Hospital of Wenling Wenling 317500, China.
  • Wang Y; Department of Thyroid and Breast Surgery, The First People's Hospital of Wenling Wenling 317500, China.
  • Chen P; Department of Surgery, The First People's Hospital of Wenling Wenling 317500, China.
Am J Transl Res ; 11(2): 683-695, 2019.
Article en En | MEDLINE | ID: mdl-30899371

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Año: 2019 Tipo del documento: Article